Exelixis | EXEL - PE Price to Earnings

Stock Price
50.13
Daily Change
-0.97 -1.90%
Monthly
12.96%
Yearly
10.42%
Q2 Forecast
49.12

Exelixis reported 13.91 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Amgen 19.84 5.47 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
Bayer 3.4 8.75 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Eisai 26.63 0.46 Dec/2025
Eli Lilly 40.27 0.06 Mar/2026
Esperion Therapeutics 129.79 129 Dec/2024
Exelixis 13.91 588.4 Mar/2026
Genmab 17.14 4.39 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Merck 16.52 2.6 Mar/2026
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novartis 20.17 2.32 Mar/2026
Pfizer 9.32 5.16 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Sanofi 15.75 1.53 Dec/2025
Takeda 46.52 188.53 Mar/2026
Xencor 29.92 3.22 Sep/2022